Dupilumab Efficacy in Asthma Patients With FEV1 60-80% Predicted on Medium-Dose ICS: liberty asthma quest Study

被引：1
|
作者：
Papi, Alberto [1 ]
Pavord, Ian D. [2 ]
Fitzgerald, J. Mark [3 ]
Corren, Jonathan [4 ]
Bardin, Philip [5 ,6 ,7 ,8 ]
Park, Hae Sim [9 ]
Rice, Megan S. [10 ]
Deniz, Yamo [11 ]
Rowe, Paul [12 ]
Staudinger, Heribert [12 ]
Amin, Nikhil [11 ]
Ruddy, Marcella [11 ]
Graham, Neil M. H. [11 ]
Teper, Ariel [12 ]
机构：
[1] Univ Hosp Santa Anna, Ferrara, Italy
[2] NIHR Oxford Biomed Res Ctr, Oxford, England
[3] Univ British Columbia, Vancouver, BC, Canada
[4] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[5] Monash Univ, Melbourne, Vic, Australia
[6] Monash Med Ctr, Melbourne, Vic, Australia
[7] Monash Univ, Clayton, Vic, Australia
[8] Monash Med Ctr, Clayton, Vic, Australia
[9] Ajou Univ, Suwon, South Korea
[10] Sanofi, Cambridge, MA USA
[11] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[12] Sanofi, Bridgewater, MA USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
Asthma; -; management;
D O I：
10.1183/13993003.congress-2019.PA538
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA538
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A Randomized, Controlled Phase 3 Study, LIBERTY ASTHMA QUEST, Evaluating the Efficacy and Safety of Dupilumab in Uncontrolled Moderate-to-Severe Asthma
    Castro, M.
    Corren, J.
    Pavord, I. D.
    Maspero, J. F.
    Wenzel, S. E.
    Rabe, K. F.
    Busse, W. W.
    Ford, L. B.
    Sher, L.
    FitzGerald, J.
    Katelaris, C.
    Tohda, Y.
    Zhang, B.
    Staudinger, H.
    Pirozzi, G.
    Amin, N.
    Ruddy, M.
    Akinlade, B.
    Khan, A.
    Chao, J.
    Martincova, R.
    Graham, N. M.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [32] Dupilumab Add-on to Medium-dose Inhaled Corticosteroid (ICS) Increases Odds of Asthma Control and Reduces FeNO Compared With Placebo Add-on to High-dose ICS
    Busse, W.
    Castro, M.
    Lugogo, N. L.
    O'Byrne, P. M.
    Bacharier, L. B.
    Xia, C.
    Hardin, M.
    Soliman, M.
    Sacks, H.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [33] Dupilumab Suppresses Inflammatory Biomarkers in Asthma Patients With or Without Allergic Rhinitis: Post Hoc Analysis of the LIBERTY ASTHMA QUEST Study
    Corren, Jonathan
    Bousquet, Jean
    Busse, William W.
    Maspero, Jorge F.
    Hanania, Nicola A.
    Ford, Linda B.
    Rice, Megan
    Lu, Yufang
    Rowe, Paul
    Harel, Sivan
    Staudinger, Heribert
    Ruddy, Marcella
    Graham, Neil M. H.
    Amin, Nikhil
    Teper, Ariel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB97 - AB97
  • [34] Long-Term 3-Year Efficacy of Dupilumab in QUEST Patients Enrolled in LIBERTY ASTHMA TRAVERSE
    Papi, A.
    Bourdin, A.
    Watz, H.
    Pavord, I. D.
    Domingo, C.
    Wechsler, M. E.
    Mao, X.
    Ortiz, B.
    Djandji, M.
    Mannent, L. P.
    Ruddy, M.
    Laws, E.
    Amin, N.
    Lederer, D. J.
    Hardin, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [35] EFFICACY OF FLUNISOLIDE HFA IN THE TREATMENT OF ASTHMA: A SUBGROUP ANALYSIS OF SEVERITY BASED ON PERCENT PREDICTED FEV1 AT SCREENING
    Bensch, G.
    Greos, L.
    Meltzer, E. O.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) : A53 - A53
  • [36] EFFICACY OF DUPILUMAB IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA AND WITH HIGH SLEEP DISTURBANCE: A POST HOC ANALYSIS FROM LIBERTY ASTHMA QUEST
    Maspero, J.
    Shafazand, S.
    Cole, J.
    Pavord, I. D.
    Busse, W. W.
    Msihid, J.
    Gall, R.
    Soler, X.
    Siddiqui, S.
    Khan, A. H.
    Gomez, L. D. P.
    Jacob-Nara, J. A.
    VALUE IN HEALTH, 2022, 25 (07) : S550 - S550
  • [37] Dupilumab Produces Rapid and Sustained Improvements in Asthma-Related Symptoms in Patients with Uncontrolled, Moderate-To-Severe Asthma from the LIBERTY ASTHMA QUEST Study
    Corren, J.
    Castro, M.
    Guillonneau, S.
    Chao, J.
    Amin, N.
    Pirozzi, G.
    Graham, N. M.
    Teper, A.
    Khan, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [38] LONG-TERM EFFICACY OF DUPILUMAB: 3-YEAR DATA OF QUEST PATIENTS WITH MODERATE-TO-SEVERE ASTHMA ENROLLED IN LIBERTY ASTHMA TRAVERSE
    Pavord, I. D.
    Papi, A.
    Bourdin, A.
    Watz, H.
    Domingo, C.
    Wechsler, M. E.
    Mao, X.
    Ortiz, B.
    Djandji, M.
    Mannent, L.
    Laws, E.
    Amin, N.
    Lederer, D. J.
    Hardin, M.
    THORAX, 2021, 76 : A53 - A54
  • [39] LONG-TERM SAFETY AND EFFICACY OF DUPILUMAB IN PATIENTS WITH ASTHMA: LIBERTY ASTHMA TRAVERSE OPEN-LABEL EXTENSION STUDY
    Pavord, Id
    Wechsler, Me
    Domingo, C.
    Papi, A.
    Bourdin, A.
    Watz, H.
    Mao, X.
    Kapoor, U.
    Khokhar, Fa
    Mannent, Lp
    Ruddy, M.
    Laws, E.
    Amin, N.
    Hardin, M.
    THORAX, 2021, 76 : A81 - A82
  • [40] Dupilumab Improved Lung Function in Patients with Uncontrolled, Moderate-to-Severe Asthma Despite Exacerbation Events During the LIBERTY ASTHMA QUEST Study
    Rabe, K. F.
    Castro, M.
    Wenzel, S. E.
    Corren, J.
    Pavord, I. D.
    Katelaris, C.
    Tohda, Y.
    Rice, M. S.
    Lu, Y.
    Rowe, P.
    Staudinger, H. W.
    Amin, N.
    Akinlade, B.
    Graham, N. M. H.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
12345